Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-14 4:04 pm Purchase |
2023-12-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Cormorant Asset Management LP | 6,038,235 12.360% |
6,038,235 (New Position) |
Filing History |
| 2023-12-08 5:28 pm Sale |
2023-12-04 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 2,337,786 5.000% |
-1,312,606 (-35.96%) |
Filing History |
| 2023-09-11 11:15 am Sale |
2023-08-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,130,137 11.800% |
-1,644,372 (-28.48%) |
Filing History |
| 2023-08-30 5:22 pm Sale |
2019-03-28 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
EW Healthcare Partners, L.P. | 3,650,392 10.400% |
-540,004 (-12.89%) |
Filing History |
| 2023-05-01 4:23 pm Purchase |
2023-04-21 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
Cormorant Global Healthcare Master Fund LP | 3,200,000 9.330% |
3,200,000 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
RA Capital Management, L.P. | 3,408,706 9.990% |
1,801,847 (+112.13%) |
Filing History |
| 2023-02-13 10:23 am Sale |
2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,411,210 9.990% |
-70,899 (-2.04%) |
Filing History |
| 2023-01-31 11:44 am Purchase |
2022-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
5,774,509 16.900% |
827,344 (+16.72%) |
Filing History |
| 2022-02-11 4:24 pm Purchase |
2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,482,109 9.990% |
1,886,945 (+118.29%) |
Filing History |
| 2022-02-10 09:13 am Purchase |
2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 1,950,000 5.750% |
450,000 (+30.00%) |
Filing History |
| 2022-02-03 2:12 pm Purchase |
2021-12-31 | 13G | FIGS, Inc. FIGS |
FRANKLIN RESOURCES INC BEN |
8,333,476 5.500% |
8,333,476 (New Position) |
Filing History |
| 2022-02-03 2:02 pm Purchase |
2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
4,947,165 14.600% |
3,533,218 (+249.88%) |
Filing History |
| 2021-08-13 4:31 pm Purchase |
2021-08-03 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
RA Capital Management, L.P. | 1,606,859 5.600% |
1,606,859 (New Position) |
Filing History |
| 2021-07-26 5:21 pm Purchase |
2021-07-14 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,595,164 5.600% |
1,595,164 (New Position) |
Filing History |
| 2021-02-12 4:06 pm Purchase |
2021-02-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
ADAGE CAPITAL PARTNERS GP LLC | 1,500,000 5.230% |
1,500,000 (New Position) |
Filing History |
| 2021-02-01 2:18 pm Purchase |
2020-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
1,413,947 7.800% |
1,413,947 (New Position) |
Filing History |
| 2021-01-21 6:21 pm Purchase |
2020-12-31 | 13D | EyePoint Pharmaceuticals, Inc. EYPT |
Ocumension Therapeutics | 3,010,722 16.600% |
3,010,722 (New Position) |
Filing History |
| 2020-11-10 10:47 am Purchase |
2020-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
FRANKLIN RESOURCES INC BEN |
1,413,750 10.600% |
1,413,750 (New Position) |
Filing History |